AIA-2000
Report
- Report Number
- 8031673-2018-03341
- Event Type
- Malfunction
- Date Received
- March 22, 2018
- Date of Event
- May 30, 2017
- Report Date
- March 22, 2018
- Manufacturer
- TOSOH CORPORATION
- Product Code
- KHO
- PMA / PMN Number
- K971103
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MD, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
TOSOH BIOSCIENCE, INC. IS SUBMITTING ON BEHALF OF THE FOREIGN MANUFACTURER, TOSOH CORPORATION, PER EXEMPTION NUMBER E2017013. THIS REPORT IS BEING SUBMITTED DUE TO A RETROSPECTIVE REVIEW CONDUCTED UNDER CAPA-2017-0007. SUBMISSION OF THIS REPORT DOES NOT CONSTITUTE AN ADMISSION THAT THE IMPORTER OR MANUFACTURER'S PRODUCT CAUSED OR CONTRIBUTED TO THE EVENT. ON 30-MAY-2017, AN FSE VISITED THE CUSTOMER SITE AND FOUND THAT EKI BOARD WAS NOT ADJUSTING UP TO THE CORRECT VALUE. HE REPLACED THE EKI BOARD AND ADJUSTED IT. ALSO, HE RECALCULATED K1 FOR BOTH MAIN AND HYBRID ARMS. THE HYBRID ARM K1 REQUIRED ADJUSTMENT WHILE THE MAIN ARM K1 DID NOT. ON 31-MAY-2017 THE FSE RETURNED TO THE FACILITY, RAN CONTROLS ON ALL ASSAYS WITH NO ERRORS ON PRETREATMENT OR MAIN ARM, AND RECHECKED ALL HYBRID ARM ALIGNMENTS. THE INSTRUMENT WAS WORKING AS INTENDED. NO FURTHER ACTIONS WERE REQUIRED BY FIELD SERVICE. THE MOST PROBABLE CAUSE OF THE REPORTED EVENT WAS A BAD EKI BOARD AND THE K1 HYBRID ARM VALUE WAS INCORRECT.
ON (B)(6) 2017, A CUSTOMER REPORTED OBTAINING ERROR 3012: PRETREATMENT REAGENT SHORTAGE AND ERROR 2081: SPECIMEN SHORTAGE DETECTED WITH THEIR AIA-2000 ANALYZER. THE CUSTOMER WAS UNABLE TO RUN E2, FSH AND LH-II PATIENT SAMPLES. A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO ADDRESS THE REPORTED EVENT, WHICH RESULTED IN DELAYED REPORTING OF E2, FSH, AND LH-II PATIENT RESULTS. THERE WAS NO INDICATION OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DELAY IN REPORTING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 207067 | AIA-2000 | AIA-2000 | KHO | TOSOH CORPORATION | AIA-2000 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |